VLA 0.00% $1.75 viralytics limited

Hi Lopez The Keynote 200 trial looks like it is tracking well...

  1. 245 Posts.
    lightbulb Created with Sketch. 20
    Hi Lopez

    The Keynote 200 trial looks like it is tracking well and the upregulation of PD-L1 in NSCLC and bladder cancer looks promising.

    I'm still disappointed at the pace of the MITCI & CAPRA trials .... still recruiting very slowly but the results are looking excellent.

    I think today's announcement will help to clarify the results from the presentation.

    GLTAH
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.